
DD Stock Forecast & Price Target
DD Analyst Ratings
Bulls say
DuPont de Nemours has demonstrated strong sales growth in its Healthcare & Water business, with organic sales increasing due to robust demand in medical packaging, biopharma, reverse osmosis, and ion exchange. Additionally, the company's focus on enhancing its product vitality index is expected to yield improved pricing and mix over the next several years, supported by new product introductions and volume increases from emerging market investments. Furthermore, the Electronics & Industrial segment stands to benefit from the expanding 5G and IoT landscapes, indicating significant potential for volume growth and a favorable shift in DuPont's market valuation as it continues to position itself as a leading multi-industrial entity.
Bears say
The analysis reveals concerns regarding DuPont de Nemours's stock primarily due to anticipated delays in the realization of synergies from its recent restructuring, which could hinder profitability. Additionally, the company is facing ongoing challenges in the electronics and construction markets, sectors that contribute significantly to its revenue streams. Moreover, the slower recovery in China further exacerbates these issues, signaling potential headwinds for DuPont's financial performance in the near term.
This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.
DD Analyst Forecast & Price Prediction
Start investing in DD
Order type
Buy in
Order amount
Est. shares
0 shares